Abstract
Asthma is amongst the commonest chronic illnesses of childhood yet there is no single objective test that results in a definitive diagnosis. Diagnosis remains clinical, especially in young children. At present, asthma diagnosis in children is best viewed as a process. The initial steps include a clinical assessment focusing on recognising characteristic clinical features from a detailed history and examination combined with a careful review of possible alternative diagnoses. Since there is no gold standard for diagnosis, clinical evaluation can only give a probability that a given child has a diagnosis of asthma. If the probability of asthma is high, the next step is frequently a trial of anti-asthma treatment, usually a low-dose of an inhaled corticosteroid and a bronchodilator. Fairly to respond to a properly taken anti-asthma treatment suggests an alternative diagnosis. If the probability is low, a diagnosis other than asthma may be suspected. Then further investigation and specialist referral may be indicated. In those with an intermediate probability tests of lung function (expiratory airway obstruction, bronchial reversibility and occasionally bronchial hyperreactivity), and tests for atopy may be helpful.
Current Pediatric Reviews
Title: Asthma in Childhood – Making the Diagnosis
Volume: 6 Issue: 2
Author(s): James Y. Paton
Affiliation:
Keywords: Children, asthma, diagnosis
Abstract: Asthma is amongst the commonest chronic illnesses of childhood yet there is no single objective test that results in a definitive diagnosis. Diagnosis remains clinical, especially in young children. At present, asthma diagnosis in children is best viewed as a process. The initial steps include a clinical assessment focusing on recognising characteristic clinical features from a detailed history and examination combined with a careful review of possible alternative diagnoses. Since there is no gold standard for diagnosis, clinical evaluation can only give a probability that a given child has a diagnosis of asthma. If the probability of asthma is high, the next step is frequently a trial of anti-asthma treatment, usually a low-dose of an inhaled corticosteroid and a bronchodilator. Fairly to respond to a properly taken anti-asthma treatment suggests an alternative diagnosis. If the probability is low, a diagnosis other than asthma may be suspected. Then further investigation and specialist referral may be indicated. In those with an intermediate probability tests of lung function (expiratory airway obstruction, bronchial reversibility and occasionally bronchial hyperreactivity), and tests for atopy may be helpful.
Export Options
About this article
Cite this article as:
Y. Paton James, Asthma in Childhood – Making the Diagnosis, Current Pediatric Reviews 2010; 6 (2) . https://dx.doi.org/10.2174/157339610791561132
DOI https://dx.doi.org/10.2174/157339610791561132 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Timely Review of State-of-the-Art Chronopharmaceuticals Synchronized with Biological Rhythms
Current Drug Delivery A Multiple-Dose, Open-Label, Safety, Compliance, and Usage Evaluation Study of Epicutaneously Applied Diractin® (Ketoprofen in Transfersome®) in Joint/Musculoskeletal Pain or Soft Tissue Inflammation
Current Drug Safety Natural Products to Anti-trypanosomal Drugs: An Overview of New Drug Prototypes for American Trypanosomiasis
Cardiovascular & Hematological Agents in Medicinal Chemistry Synthesis and In Vitro Evaluation of Some Isatin-Thiazolidinone Hybrid Analogues as Anti-Proliferative Agents
Medicinal Chemistry Snake Venom Proteins and Peptides as Novel Antibiotics Against Microbial Infections
Current Proteomics Recent Advances on Radionuclide Labeled Hypoxia-Imaging Agents
Current Pharmaceutical Design Drug Targets in Cytomegalovirus Infection
Infectious Disorders - Drug Targets Inhibitors of Cyclin Dependent Kinases: Useful Targets for Cancer Treatment
Current Cancer Drug Targets Small Animal Computed Tomography Imaging
Current Medical Imaging Novel Marine-Derived Anti-Cancer Agents
Current Pharmaceutical Design Tumor Necrosis Factor Inhibitors from Poxviruses with An Emphasis on Tanapoxvirus-2L Protein
Recent Patents on DNA & Gene Sequences Bortezomib in the Treatment of Cancer
Recent Patents on Anti-Cancer Drug Discovery Oncogene Expression Modulation in Cancer Cell Lines by DNA G-Quadruplex-Interactive Small Molecules
Current Medicinal Chemistry Targeting JAK3 Tyrosine Kinase-Linked Signal Transduction Pathways with Rationally-Designed Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Phosphatidylinositol 3-Kinase Isoforms as Novel Drug Targets
Current Drug Targets Substituted Benzimidazole Derivatives as Angiotensin II -AT1 Receptor Antagonist: A Review
Mini-Reviews in Medicinal Chemistry From CHD Susceptibility Genes to New Therapeutics
Current Pharmacogenomics Computational Study of Nanosized Drug Delivery from Cyclodextrins, Crown Ethers and Hyaluronan in Pharmaceutical Formulations
Current Topics in Medicinal Chemistry Therapeutic Challenges in Neuroendocrine Tumors
Anti-Cancer Agents in Medicinal Chemistry The Pharmacology of Cyclic Nucleotide-Gated Channels: Emerging from the Darkness
Current Pharmaceutical Design